Coronavirus News and Research

RSS

CRISPR platform can accelerate potential treatment targets for SARS-CoV-2

Synthego has provided multiple CRISPR-based engineered cell lines to speed up the analysis of promising treatment targets for SARS-CoV-2.

19 Oct 2020

Researchers identify potential drugs that could be repurposed as pan-coronavirus treatments

A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses - SARS-CoV-1, SARS-CoV-2, and MERS-CoV - with the aim of finding vulnerabilities shared by these three pathogens.

16 Oct 2020

Climate experts release assessment of carbon dioxide emissions

An international team of climate experts, including Earth system scientists at the University of California, Irvine, today released an assessment of carbon dioxide emissions by industry, transportation and other sectors from January through June, showing that this year's pandemic lockdowns resulted in a 9 percent decline from 2019 levels.

16 Oct 2020

Peptide therapy prevents overreaction of the immune system against infections

Individuals require enough action to remove offensive viruses or bacteria, but not so much that their body suffer a considerable damage.

From UC San Diego 15 Oct 2020

Lymphocytes play crucial role in controlling virus shedding in asymptomatic COVID-19 patients

COVID-19 remains stubbornly inconsistent. More than a million people have died and 35 million have been diagnosed, but a large fraction of people infected with the coronavirus--about 45%, according to recent estimates--show no symptoms at all.

15 Oct 2020

Immune failure can cause serious COVID-19

While most people dying from COVID-19 are elderly, up to 5-10% of younger adults and children can also be seriously infected by the SARS-CoV-2 virus.

15 Oct 2020

Study shows lasting immunity offered by SARS-CoV-2 antibodies

One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long.

14 Oct 2020

Researchers identify a promising treatment for COVID-19 infection

An effective method for treating the 2003 SARS epidemic, also works on the closely associated SARS-CoV-2 virus.

5 Oct 2020

Neanderthal gene variant associated with higher risk of developing severe COVID-19

Research has revealed that a part of DNA, which causes a almost three times higher risk of developing severe COVID-19, is inherited from Neanderthals.

5 Oct 2020

New mobile app analyzes SARS-CoV-2 genome on a smartphone

A new mobile app has made it possible to analyse the genome of the SARS-CoV-2 virus on a smartphone in less than half an hour.

30 Sep 2020

Researchers identify risk factors for COVID-19 mortality

Scientists have proposed that carriers of two genetic mutations PiS and PiZ face a greater risk for severe illness and even death from COVID-19 disease.

25 Sep 2020

Researchers identify role of glycans in SARS-CoV-2 spike protein

With a surge in the COVID-19 cases, scientists are working actively to develop therapies and vaccines to impede SARS-CoV-2.

25 Sep 2020

T-cell-based vaccine strategy provides broader protection against influenza

As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza.

24 Sep 2020

Druggable pocket in SARS-CoV-2 Spike protein can help eliminate COVID-19

Researchers have identified a druggable pocket in the SARS-CoV-2 Spike protein that could be utilized to prevent the virus from infecting human cells.

24 Sep 2020

Irisin hormone could have therapeutic effect on COVID-19 patients

A study conducted by researchers at São Paulo State University (UNESP) suggests that irisin, a hormone secreted from muscles in response to exercise, could have a therapeutic effect on COVID-19 patients.

23 Sep 2020

Nanoparticle SARS-CoV-2 tool could accelerate the search for drugs

A team of scientists from the National Center for Advancing Translational Sciences and Naval Research Laboratory in Washington, D.C., has developed a new tool that mimics how SARS-CoV-2 -- the virus that causes COVID-19 -- infects a cell, information that could potentially speed the search for treatments against the disease.

22 Sep 2020

Researchers develop low-cost CRISPR method to detect SARS-CoV-2

In March 2020, scientists started to design a new, cost-efficient, CRISPR-based diagnostic platform to spot infectious diseases, such as SARS-CoV-2.

22 Sep 2020

Researchers develop highly scalable and accurate antibody test for COVID-19

An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.

14 Sep 2020

New study can help develop effective COVID-19 vaccine

According to a new study, a detailed analysis of antibody responses in patients affected by COVID-19 could help develop an effective vaccine.

14 Sep 2020

Sociological study focuses on perceptions about food purity and impurity

Is an oozing apple with fuzzy white mold better than one that is fresh and green a month after you bought it? Yes, according to a new sociological study of Danes' perceptions about food 'purity' and 'impurity'.

11 Sep 2020